
    
      The objective of this study is to demonstrate an improved clinical performance of the
      visually read QuickVue Influenza A+B test with nasal and nasopharyngeal swab specimens.
      Clinical performance will be based on comparison of QuickVue results to either cell culture
      or an FDA-cleared molecular test at one or more Reference Laboratories.
    
  